Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice

Production Office, Frontiers

doi:10.3389/fphar.2023.1204546

ERRATUM article

Front. Pharmacol. , 20 April 2023

Sec. Experimental Pharmacology and Drug Discovery

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1204546

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice

This article is an erratum on:

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
1. Read original article

Frontiers Production Office*

Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice

by Wu J, Jia S, Xu B, Yao X, Shao J, Yao J, Cen D and Yao X (2023). Front. Pharmacol. 14:1157200. doi: 10.3389/fphar.2023.1157200

Due to a production error, an author name was incorrectly spelled as “Benghong Xu”. The correct spelling is “Benhong Xu”. The publisher apologizes for this mistake.

The original version of this article has been updated.

Keywords: bicyclol, NAFLD, NASH, proteomics, multiple pathways

Citation: Frontiers Production Office (2023) Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice. Front. Pharmacol. 14:1204546. doi: 10.3389/fphar.2023.1204546

Received: 12 April 2023; Accepted: 12 April 2023;
Published: 20 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good